Search Within

Department of Medicine

Formats
  1. Journal Article (19596)
  2. Meeting Abstract (16046)
  3. Review (1152)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22326)
  2. Hematologic Malignancies, Division of (13280)
  3. Center for Hematologic Malignancies (11063)
  4. GSK Faculty (10648)
  5. Survivorship Research (9336)
  6. Division of Subspecialty Medicine (7544)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1084)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2287)
  6. Nature Publishing Group (2111)

More Publishers

Results (39635)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of cisplatin and escalating doses of irinotecan given weekly with concurrent radiation in esophageal cancer
    Meeting Abstract

    Ilson, D.; Anderson, S.; Bains, M.; O'Reilly, E.; Kelsen, D.; Karpeh, M.; Saltz, L.; Gonzalez, G.; Minsky, B.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Rapid generation of Epstein Barr virus (EBV) specific cytotoxic T lymphocytes (CTL) depleted of host-reactive T cells using allogenic HLA homozygous haplotype matched EBV transformed B cells for in vitro sensitization
    Meeting Abstract

    Doubrovina, E. S.; O'Reilly, R. J.
    Blood (2000)

    Fulltext@MSK | Save
  • Arsenic trioxide (ATO) in relapsed acute promyelocytic leukemia (APL): The combine results and follow-up from the US pilot and multicenter trials
    Meeting Abstract

    Soignet, S. L.; Frankel, S.; Tallman, M.; Douer, D.; Scheinberg, D. A.; Dahlberg, S.; Kantarjian, H.; Stone, R.; Sievers, E.; Kalaycio, M.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • Therapeutic levels of hemoglobin produced in bone marrow chimeras expressing lentivirus-encoded human beta-globin
    Meeting Abstract

    Sadelain, M.
    Blood Cells, Molecules, and Diseases (2000)

    Fulltext@MSK | Save
  • Diltiazem reduces the incidence of atrial arrhythmias after thoracic surgery
    Meeting Abstract

    Amar, D.; Roistacher, N.; Rusch, V. W.; Leung, D. H. Y.; Ginsburg, I.; Zhang, H.; Bains, M. S.; Downey, R. J.; Korst, R. J.; Ginsberg, R. J.
    Circulation (2000)

    Fulltext@MSK | Save
  • Design and synthesis of small molecule inhibitors of the Hsp90 chaperone
    Meeting Abstract

    Chiosis, G.; Timaul, M. N.; Sepp-Lorenzino, L.; Zheng, F. Z. F.; Lucas, B.; Danishefsky, S. J.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Cytarabine with a single high dose of idarubicin as induction therapy for adults with relapsed or refractory acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Weiss, M. A.; Aliff, T. B.; Tallman, M. S.; Frankel, S. R.; Kalaycio, M. E.; Maslak, P. G.; Scheinberg, D. A.; Roma, T. E.
    Blood (2000)

    Fulltext@MSK | Save
  • Iodine I 131 tositumomab for patients with low-grade or transformed low-grade NHL: Complete response data
    Meeting Abstract

    Leonard, J. P.; Zelenetz, A. D.; Vose, J. M.; Radford, J. A.; Wahl, R. L.; Rohatiner, A.; Kroll, S.; Stagg, R.; Nadeau, K.; Valente, N.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • Combination pentostatin and cyclophosphamide: Complete responses without severe myelosuppression in previously treated patients with CLL
    Meeting Abstract

    Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Horgan, D. E.
    Blood (2000)

    Fulltext@MSK | Save
  • The outcome of patients with primary refractory Hodgkin's disease (HD) treated with high dose chemoradiotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hedrick, E. E.; Gonzalez, M.; Yahalom, J.
    Blood (2000)

    Fulltext@MSK | Save